Registry for patients with type 2 diabetes and heart disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects clinical data from patients with type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD) who attend a specialized cardio-metabolic clinic at the Heart Hospital. Patients are examined by both cardiologists and diabetologists to optimize their metabolic and hemodynamic control. The registry aims to gather important health information that can inform future clinical research and improve patient care for this high-risk population. Data will be securely stored in a password-protected database.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with type 2 diabetes mellitus
* Newly diagnosed heart disease, such as ischemic heart disease, heart failure.

Exclusion Criteria:

* Patients who do not have type 2 diabetes mellitus
* Preexisting heart disease

Where it's running

• Hamad Medical Coorporation
  Doha, Qatar Recruiting

Study contacts

• Principal investigator: Jassim Al-Suwaidi, MD — Hamad Medical Coorporation
• Study coordinator: Jassim Al-Suwaidi, MD
• Email: jalsuwaidi@hamad.qa
• Phone: 55823041

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala

  This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.

  Recruiting Uppsala University · Uppsala · NCT07614659

• Streamlined renal denervation with Spyral for uncontrolled high blood pressure

  This trial will test whether a shorter, simpler renal denervation procedure using the Symplicity Spyral system can lower blood pressure in adults with uncontrolled hypertension.

  Recruiting at 20 sites Medtronic Vascular · Melbourne and 20 other locations · NCT07115953

• Gemini multi-organ denervation for uncontrolled high blood pressure

  The Gemini System is being tested to see if multi-organ denervation is safe and can lower blood pressure in adults with uncontrolled hypertension, with or without high cardiovascular risk.

  Recruiting at 18 sites Medtronic Vascular · Stanford, California and 17 other locations · NCT06907147

• Evaluating human placental membrane products for treating nonhealing diabetic foot and venous leg ulcers

  This study is testing whether using human placental products along with regular care can help people with stubborn diabetic foot and leg ulcers heal better.

  Recruiting C5 Biomedical · Metairie, Louisiana · NCT06674980

• Investigating cardiovascular disease risk factors in elderly diabetic patients

  This study looks at how common heart disease risk factors are in older people with diabetes to see how they manage their health over ten years.

  Recruiting Shanghai Zhongshan Hospital · Suzhou, Jiangsu · NCT04544527

• Preventing heart disease in high-risk diabetes patients

  This study is testing whether stronger medication for adults with type 2 diabetes and high heart disease risk can help prevent heart problems compared to regular treatment.

  Recruiting Phase 4 National Heart Centre Singapore · Singapore · NCT04286399

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.